5-HT1A Receptor Agonists Enhance Pyramidal Cell Firing in Prefrontal Cortex Through a Preferential Action on GABA Interneurons

Preferential in vivo action of F15599, a novel 5-HT1A receptor agonist, at postsynaptic 5-HT1A receptors

(2010) L Lladó-Pelfort et al.   BRITISH JOURNAL OF PHARMACOLOGY

F15599, a preferential post-synaptic 5-HT1A receptor agonist: Activity in models of cognition in comparison with reference 5-HT1A receptor agonists

(2010) Ronan Depoortère et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Simultaneous projections from prefrontal cortex to dopaminergic and serotonergic nuclei

(2010) Pablo Vázquez-Borsetti et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)

(2009) Michael Davidson et al.   AMERICAN JOURNAL OF PSYCHIATRY

The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation

(2009) T.W. Robbins et al.   Annual Review of Neuroscience

Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1Areceptor agonist

(2009) A Newman-Tancredi et al.   BRITISH JOURNAL OF PHARMACOLOGY

The relevance of the functional 5-HT1A receptor polymorphism for attention and working memory processes during mental rotation of characters

(2009) Christian Beste et al.   NEUROPSYCHOLOGIA

Does stimulation of 5-HT1A receptors improve cognition in schizophrenia?

(2008) Herbert Y. Meltzer et al.   BEHAVIOURAL BRAIN RESEARCH

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET

GABA Neurons and the Mechanisms of Network Oscillations: Implications for Understanding Cortical Dysfunction in Schizophrenia

(2008) G. Gonzalez-Burgos et al.   SCHIZOPHRENIA BULLETIN